Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Viral Vector Affinity Resin Market Revenue Growth Supported By A CAGR Of 1.3% Through 2030
The market for viral vector affinity resins has experienced significant expansion, projected to increase from an estimated $0.62 billion in 2025 to $0.72 billion by 2026, reflecting a compound annual growth rate of 16.2%. This upward trend during the preceding period was fueled by heightened research into viral vectors, a greater reliance on chromatography within bioprocessing operations, advancements in gene therapy development, a growing need for purification methods that can be scaled effectively, and enhancements in the technologies used for resin production.
The market for viral vector affinity resins is projected for substantial expansion in the upcoming years, anticipating a valuation of $1.3 billion by 2030, driven by a compound annual growth rate of 15.9%. This upward trajectory in the forecast period is fueled by several key factors, including the escalating commercialization of gene therapies, a growing need for efficient high-throughput purification systems, the broadening scope of vaccine development initiatives, a heightened emphasis on economical downstream processing techniques, and the increasing utilization of bespoke affinity resin solutions. Dominant trends anticipated during this timeframe encompass a greater embrace of high-capacity affinity resins, a surge in requirements for purification solutions targeting AAV and lentiviruses, the expanding deployment of single-use chromatography systems, advancements in the development of ligand-specific resins, and a more concentrated effort on processing viral vectors to achieve superior purity levels.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30426&type=smp
Viral Vector Affinity Resin Market Industry Drivers: What Is Driving Revenue Growth?
The burgeoning utilization of gene-based therapies is poised to stimulate the expansion of the viral vector affinity resin sector. These sophisticated treatments, which leverage DNA, RNA, or viral vectors to influence cellular gene expression, are gaining traction due to improved delivery methods facilitating secure, effective, and precise genetic material transfer into cells. Viral vector affinity resins are instrumental in this rise by offering solutions for purification that are both highly pure and scalable, thus supporting the manufacture of viral vectors. By efficiently separating viral vectors from contaminants, these resins alleviate complexities in downstream processing, enhancing manufacturing efficiency and enabling wider clinical and commercial deployment. A notable indication of this trend is the U.S. Food and Drug Administration’s approval of six gene therapy products in 2023, an increment from the five approved in 2022, as reported by the American Society of Gene & Cell Therapy in December 2024. Consequently, the escalating adoption of gene-based therapeutics is a direct catalyst for the growth observed in the viral vector affinity resin market.
Viral Vector Affinity Resin Market Driver: Increased Spending On Healthcare Fuels Market Expansion Through Greater Investment In Cutting-Edge Biomanufacturing And Gene Therapy Advancement
An augmentation in healthcare spending is anticipated to be a primary driver for the expansion of the viral vector affinity resin market. Healthcare expenditure encompasses all financial outlays associated with medical services, treatments, facilities, research endeavors, and public health programs aimed at preserving or enhancing wellness. The heightened demand for healthcare services is largely attributable to the increasing incidence of chronic illnesses, which necessitate prolonged and expensive therapeutic interventions. This surge in healthcare budgets, in turn, invigorates the viral vector affinity resin market by encouraging greater investment in sophisticated biomanufacturing processes and purification technologies. Enhanced financial backing for gene and cell therapies directly elevates the need for premium viral vector production, where affinity resins prove essential for achieving efficient purification, maximizing yields, and adhering to stringent regulatory requirements. Providing a relevant statistic, the Office for National Statistics in the UK reported in May 2024 that total healthcare expenditure experienced a 5.6% nominal increase in 2023, representing a 0.9% acceleration in growth compared to the preceding year. Therefore, escalating healthcare expenditure plays a significant role in propelling the growth trajectory of the viral vector affinity resin market.
Viral Vector Affinity Resin Market Segmentation And Category Breakdown
The viral vector affinity resin market covered in this report is segmented –
1) By Product Type: Adenoviral Vector Affinity Resin, Lentiviral Vector Affinity Resin, Adeno-Associated Viral (AAV) Vector Affinity Resin, Retroviral Vector Affinity Resin, Other Product Types
2) By Application: Gene Therapy, Vaccine Development, Cell Therapy, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations
Subsegments:
1) By Adenoviral Vector Affinity Resin: Cell Lysis-Based Adenoviral Vector Affinity Resin, Chromatography-Based Adenoviral Vector Affinity Resin, High-Capacity Adenoviral Vector Affinity Resin, Prepacked Column Adenoviral Vector Affinity Resin
2) By Lentiviral Vector Affinity Resin: High-Purity Lentiviral Vector Affinity Resin, Column-Based Lentiviral Vector Affinity Resin, Membrane Chromatography Lentiviral Vector Affinity Resin, Single-Use Lentiviral Vector Affinity Resin
3) By Adeno-Associated Viral Vector Affinity Resin: Serotype-Specific Adeno-Associated Viral Vector Affinity Resin, High-Capacity Adeno-Associated Viral Vector Affinity Resin, Prepacked Column Adeno-Associated Viral Vector Affinity Resin, Ligand-Based Adeno-Associated Viral Vector Affinity Resin
4) By Retroviral Vector Affinity Resin: High-Selectivity Retroviral Vector Affinity Resin, Column-Based Retroviral Vector Affinity Resin, Membrane-Based Retroviral Vector Affinity Resin, Prepacked Retroviral Vector Affinity Resin
5) By Other Product Types: Hybrid Viral Vector Affinity Resin, Multimodal Viral Vector Affinity Resin, Recombinant Ligand Affinity Resin, Customized Viral Vector Affinity Resin
Viral Vector Affinity Resin Market Competitive Analysis Of Major Industry Participants
Major companies operating in the viral vector affinity resin market are Thermo Fisher Scientific, GE Healthcare Technologies Inc., Repligen Corporation, Creative Biolabs, JNC Corporation, Aptamer Group, ChromaGenix Inc., Cytiva (Danaher Corporation), Merck KGaA, Sartorius AG, Purolite Life Sciences, Tosoh Bioscience, Bio-Rad Laboratories, Avantor Inc., Pall Corporation, Takara Bio Inc., Cube Biotech, Agilent Technologies, Promega Corporation, Kaneka Corporation
Access The Complete Viral Vector Affinity Resin Market Report:
https://www.thebusinessresearchcompany.com/report/global-viral-vector-affinity-resin-market-report
Viral Vector Affinity Resin Market Regional Analysis And Leading Geography
North Americawas the largest region in the viral vector affinity resin market in 2025. The regions covered in the viral vector affinity resin market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
